Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Channels (Austin, Tex.)|November 12, 2015
Validation of ion channel targetsAaron C Gerlach, Brett M AntonioPharmaceutical Research|July 24, 2019
Repurposing Approved Drugs as Inhibitors of K<sub>v</sub>7.1 and Na<sub>v</sub>1.8 to Treat Pitt Hopkins SyndromeSean Ekins, Jacob Gerlach, Kimberley M Zorn, et al.Proceedings of the National Academy of Sciences of the United States of America|November 16, 2018
TRPA1 ankyrin repeat six interacts with a small molecule inhibitor chemotypeWei Chou Tseng, David C Pryde, Katrina E Yoger, et al.British Journal of Pharmacology|November 19, 2017
GI-530159, a novel, selective, mechanosensitive two-pore-domain potassium (K<sub>2P</sub> ) channel opener, reduces rat dorsal root ganglion neuron excitabilityAlexandre J C Loucif, Pierre-Philippe Saintot, Jia Liu, et al.ACS Medicinal Chemistry Letters|February 20, 2018
Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK InhibitorsMatthew F Sammons, Sujay V Kharade, Kevin J Filipski, et al.Epilepsia|March 26, 2018
A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsyTalia A Atkin, Chani M Maher, Aaron C Gerlach, et al.Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channelsKen McCormack, Sonia Santos, Mark L Chapman, et al.The Journal of Clinical Investigation|January 16, 2024
APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney diseaseSomenath Datta, Brett M Antonio, Nathan H Zahler, et al.British Journal of Pharmacology|January 28, 2015
A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitabilityClaire Elizabeth Payne, Adam R Brown, Jonathon W Theile, et al.Pageof 1